This promotional non-CNE symposium, sponsored by Boehringer Ingelheim Pharmaceuticals, Inc., will provide an opportunity to learn more about metastatic NSCLC with common EGFR mutations, including biomarker testing, treatment options, and supportive care via clinical case studies.
This program is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
